Spectral AI Schedules 2026 Second Quarter Financial Results and Conference Call
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Spectral AI (Nasdaq: MDAI) will release its 2026 second quarter financial results for the period ended June 30, 2026 on Tuesday, August 11, 2026, after the close of the Nasdaq market. A conference call to discuss the results is scheduled for 5:00 p.m. Eastern Time the same day, with U.S. and international dial-in numbers and a simultaneous webcast available via the Events section of the company’s investor relations website.
Details
News Market Reaction – MDAI
On Jul 30, the first trading day after this news, MDAI closed 5.33% above the previous close. Our momentum scanner recorded 6 alerts for this stock that day.
Data tracked by StockTitan Argus for the Jul 30 session.
Key Figures
- Quarter End
- June 30, 2026
- Second quarter financial results
- Results Date
- August 11, 2026
- Results reported after Nasdaq market close
- Conference Call Time
- 5:00 pm Eastern Time
- August 11, 2026 results call
Historical Context
-
Named Darcy Bajko chief commercial officer to lead global DeepView commercialization.
-
Presented DeepView research and received a first-prize oral presentation award.
-
Partnered with the wound management foundation for Wound Healing Awareness Month.
-
Announced conference participation and projected first commercial sales by year-end 2026.
-
Reported approval of annual meeting proposals, including share reservation authorization.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
DALLAS, July 29, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that it will report financial results for the second quarter ended June 30, 2026 on Tuesday, August 11, 2026, after the close of the Nasdaq stock market. The Company will host a corresponding conference call at 5:00 pm Eastern Time on the same day to discuss its financial results.
Investors interested in participating in the live call can dial into the conference call as follows:
- 833-890-6620 – U.S.
- 412-564-3789 – International
In addition, a simultaneous webcast of the financial results call may be accessed online from the Events section of the Investor Relations page of the Company’s website at https://investors.spectral-ai.com/news-events/events.
About Spectral AI
Spectral AI, Inc. is a Dallas-based predictive AI company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, with initial applications involving patients with burns. The Company is working to revolutionize the management of wound care by “Seeing the Unknown®” with its DeepView System. The DeepView System is a predictive diagnostic device that offers physicians an objective and immediate assessment of a wound’s healing potential prior to treatment or other medical intervention. With algorithm-driven results and a goal to exceed the current standard of care, the DeepView System provides fast and accurate treatment insights to improve patient outcomes and reduce healthcare costs. Spectral AI has been named to TIME’s list of World’s Top HealthTech companies 2025. For more information about the DeepView System, visit www.spectral-ai.com.
Forward-Looking Statements
Certain statements made in this release are “forward looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995, including statements regarding the Company’s strategy, plans, objectives, initiatives and financial outlook. When used in this press release, the words “estimates,” “projected,” “expects,” “anticipates,” “forecasts,” “plans,” “intends,” “believes,” “seeks,” “may,” “will,” “should,” “future,” “propose” and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside Company’s control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. As such, readers are cautioned not to place undue reliance on any forward-looking statements.
Investors should carefully consider the foregoing factors, and the other risks and uncertainties described in the “Risk Factors” sections of the Company’s filings with the US Securities and Exchange Commission, including the Company’s Registration Statement and the other documents filed by the Company. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements.
| Investors: The Equity Group | |
| Devin Sullivan Managing Director Devin.Sullivan@theequitygroup.com | Conor Rodriguez Associate Conor.Rodriguez@theequitygroup.com |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.